| Project | Period | Location(s) | N | Primary outcome | Study name | Principal Investigator | Institute |
|---|
| CORESMA | -- | 2 locations in
Germany, Nepal | 9000 | Seroprevalence of SARS-Cov-2 antibodies in Nepal and Germany | Covid-19 Outbreak Response combining E-health, Serolomics, Modelling, Artificial Intelligence and Implementation Research | Gérard Krause | Helmholtz HZI |
| MuSPAD | 2020-06 -- 2021-05 | 5 locations in
Germany | 60000 | Seroprevalence, stratified by age and over time | Multilocal and serial prevalence study for antibodies against SARS-2 coronavirus in Germany | Gérard Krause | Helmholtz HZI |
| SARS-CoV-2 seroprevalence study | 2020-07 -- 2020-10 | 1 location in
Germany | 1500 | Seroprevalence for SARS-CoV-2, stratified by age over time | Serial cross-sectional seroprevalence study of SARS-CoV-2 infection during and post-epidemic periods in Heidelberg and the Rhein-Neckar region, Germany | Claudia Denkinger | University Hospital Heidelberg, Division of Tropical Medicine |
| SESCiB | 2020-09 -- 2021-04 | 1 location in
Colombia | 1000 | (1) Seroprevalence of SARS-Cov-2, (2) Asymptomatic infection ratio, (3) Associated clinical, socioeconomic, and demographic factors. | Seroepidemiologic study on SARS CoV2 infection in scholar children in Bogotá, Colombia | Gérard Krause and Fernando Pio De La Hoz Restrepo | Helmholtz (HZI) and Universidad Nacional de Colombia |
| CoNAN | 2020-05 -- 2020-05 | 1 location in
Germany | 626 | Seroprevalence for SARS-CoV-2 | Seroprevalence of SARS-CoV-2 antibodies in an entirely PCR sampled and quarantined community after a COVID-19 outbreak - the CoNAN study | Mathias W. Pletz and Sebastian Weis | Institute for Infectious Diseases and Infection Control, Jena University Hospital (07747 Jena, Germany) |